Related Experiment Video

Updated: Aug 30, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock

M D Hibbard1, D R Holmes, K R Bailey

  • 1Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.

Journal of the American College of Cardiology
|March 11, 1992
PubMed

Insights

Percutaneous transluminal coronary angioplasty significantly improves survival in patients with acute myocardial infarction and cardiogenic shock. Successful angioplasty offers a survival advantage, even when considering other patient factors.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock complicating acute myocardial infarction (AMI) has a high mortality rate.
  • Percutaneous transluminal coronary angioplasty (PTCA) is a potential treatment option.
  • Previous studies suggest modest survival benefits with emergency surgical revascularization and thrombolytic therapy.

Purpose of the Study:

  • To retrospectively review patient records to determine if coronary angioplasty improves survival in AMI with cardiogenic shock.
  • To compare outcomes between successful and unsuccessful angioplasty procedures.

Main Methods:

  • Retrospective review of 45 patients with AMI complicated by cardiogenic shock who underwent angioplasty.
  • Patients were divided into two groups: successful dilation (n=28) and unsuccessful angioplasty (n=17).
  • Multivariate analysis was used to assess survival advantage, accounting for factors like left main coronary artery disease, age, and prior myocardial infarction.

Main Results:

  • Overall hospital survival rate was 56% (71% in successful angioplasty group vs. 29% in unsuccessful group).
  • Successful angioplasty was associated with a statistically significant survival advantage (p = 0.014) after multivariate analysis.
  • At a mean follow-up of 2.3 years, the survival rate for hospital survivors was 80%.

Conclusions:

  • Percutaneous transluminal coronary angioplasty significantly improves survival in patients experiencing cardiogenic shock due to acute myocardial infarction.
  • Successful dilation of the infarct-related artery is a key determinant of improved short-term and long-term survival.
  • While angioplasty offers survival benefits, a substantial proportion of survivors require re-hospitalization for cardiac evaluation and management.

More Related Videos

The Intra-Aortic Balloon Pump06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...